pifithrin has been researched along with Atrophy in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turcato, F | 1 |
| Kim, P | 1 |
| Barnett, A | 1 |
| Jin, Y | 1 |
| Scerba, M | 1 |
| Casey, A | 1 |
| Selman, W | 1 |
| Greig, NH | 1 |
| Luo, Y | 1 |
1 other study available for pifithrin and Atrophy
| Article | Year |
|---|---|
Sequential combined Treatment of Pifithrin-α and Posiphen Enhances Neurogenesis and Functional Recovery After Stroke.
Topics: Animals; Atrophy; Benzothiazoles; Cell Differentiation; Cell Proliferation; Cell Self Renewal; Cell | 2018 |